Insight on What Matters - So You Can Transform Your Business.
The therapeutic field of adoptive cell therapy (ACT) in cancer has expanded dramatically in recent years, both in investment activity and technology proliferation. Tune in to our web panel discussion to find out what experts think is in store for this exciting field.
Below are several areas of your company that will be scrutinized by a buyer and can potentially kill your deal.
Some recommended considerations for entering into an M&A process are highlighted below.
We recently sat with the experts at LMK Clinical Research Consulting to get their perspective on electronic Trial Master File (eTMF) challenges and best practices.
The healthy valuations achieved by sellers have been supported by lenders’ willingness to finance packaging acquisitions, with leverage multiples today sometimes surpassing 7.0x total debt / EBITDA.
The team at the National Cybersecurity Society has developed this fact sheet to help you develop a Work from Home policy for your specific business situation.
So, what should you consider when evaluating potential M&A professionals who all claim they’re the best for the job? It may seem a little far-fetched, but we suggest evaluating potential M&A advisors much like you would a babysitter. It’s really not that far-fetched. After all, your business is your baby.
In light of our March 2017 web panel discussion, we sat down with Dr. Ravi Kiron, Managing Partner at Biopharm Strategy Advisors and moderator of the webinar, to find out whether this area could revolutionize the healthcare industry of the future or whether we are treading on dangerous ground that we know little about.
When evaluating virtual data rooms for your application, look for the following characteristics and features.
In this webinar, our speaker, Lucia Mokres, the Founder and Principal of Araneae Biotech Consulting, will examine the complexities of this scientific founder knowledge gap and explore why even when aware of this knowledge gap many founders are overwhelmed, resistant, unfamiliar, unaware, and unable to...